Lexaria Bioscience amends its certificate of incorporation
Lexaria Bioscience Corp. filed an exhibit to amend its certificate of incorporation, updating the document formerly titled the certificate of change to amended certificate of incor…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Lexaria Bioscience Corp. filed an exhibit to amend its certificate of incorporation, updating the document formerly titled the certificate of change to amended certificate of incor…
Open Lending Corporation filed an amendment to its certificate of incorporation. The action reinforces corporate governance by confirming that the board of directors manages the co…
Anavex Life Sciences filed an IND for ANAVEX2-73 targeting early Alzheimer's disease. The company implemented a disciplined data-driven strategy focusing on FDA engagement.
Replimune Group filed a Biologics License Application for RP1 combined with nivolumab to treat advanced cutaneous melanoma following anti-PD-1 failure. The filing relies on a singl…
Winchester Bancorp has amended its bylaws to comply with standard practice by aligning its fiscal year with the calendar year ending December 31, ending June 30.
Extreme Networks amended its existing revolving credit agreement to extend maturity to July 29, 2027, confirming financial stability and continued liquidity access.
Myers Industries Inc. agreed to amend its loan agreement and release specified subsidiaries from guarantees, effective July 28, 2026.
EyePoint Inc. has completed enrollment for its pivotal DURAVYU trials for diabetic macular edema, achieved in just five months with 480 patients. Topline data is anticipated in 4Q …
Southern Cross Acquisition I Corp. has announced that its Units will split into trading components on July 31, 2026. This corporate action increases investment flexibility by allow…
Federal Reserve issues the FOMC statement.
Ramaco Resources filed an SEC 8-K including an Initial Assessment Report for its Brook Mine Critical Minerals Project detailing a preliminary study scope, costs, and execution stra…
The BDC amended its declaration of trust to align with Japanese investment regulations regarding shareholder reporting. Such updates reflect adherence to local compliance framework…
Dyne Therapeutics reports BLA for z-rostudirsen accepted by FDA with Priority Review. The company also cleared an IND for DYNE-302 in FSHD, extending its pipeline via the FORCE pla…
Splash Beverage Group and Argent Biopharma amended their agreement to expand the field to veterinary purposes and set different royalty rates of 15% for human and 10% for veterinar…
The FDA today licensed Ezplaz Freeze Dried Plasma, marking the first freeze-dried plasma product licensed for use in the United States.
VenHub Global filed a Certificate of Amendment to its Articles of Incorporation, effective July 28, 2026. The semiconductor distributor filed the amendment, a regulatory change to …
SCWorx Corp. received confirmation from the Nasdaq Hearings Panel that it completed a required benchmark to maintain its listing on the Nasdaq Capital Market. This partial complian…
Capricor Therapeutics reported positive Phase 3 HOPE-3 trial data for Deramiocel, demonstrating efficacy and potentially accelerating the regulatory review process for its first FD…
Pulse Biosciences reports enrollment is ahead of schedule in its NANOPULSE-AF pivotal study, driven by investigator enthusiasm and an intuitive workflow. This could positively impa…
Alliance Entertainment Holding Corp filed a Third Amended and Restated Certificate of Incorporation to amend its Existing Certificate in its entirety in accordance with the DGCL.